NANO Nuclear Energy, Inc. (NNE)

NASDAQIndustrialsElectrical Equipment & PartsSnapshot 2026-10-23

$12.16-2.95%

Close 2026-10-23 · 1-day change

Investment OutlookAs of Oct 25, 2026

What could strengthen or challenge NANO Nuclear Energy, Inc.’s outlook?

The long-term thesis, the evidence coming in, and the environment around it. Thesis dated Jul 8, 2026.

Higher potential upsideImproving expectations

Next-FY EPS estimate change · 30 days

Comparable estimates unavailable

+10% or more+5%0%−5%−10% or less

A matching fiscal period and sufficient coverage are required.

Higher risk of downsideWeakening expectations

One observable signal. This measures changing earnings expectations, not the probability of a gain or loss.

How this is measured

The calculation requires same-period, same-provider snapshots, positive EPS, at least five analysts and a baseline within three days of the requested lookback.

Measure / period	Management expectations	Analyst expectations
Quarter ending 2026-12-30
Revenue	—	1.94M
EPS	—	-0.295
Annual ending 2027-09-30
Revenue	—	7.29M
EPS	—	-1.225
Annual ending 2028-09-30
Revenue	—	8.27M
EPS	—	-1.48

Management figures unavailable.

What the Thesis Depends On

4 published thesis conditions, with dated milestones shown separately.

Key Factor	Why It Matters	Current Status	Break Condition	Latest Evidence
Complete NRC formal review and begin construction	It plans to finish NRC review in 2027 and start construction.	Improving	NRC review delayed beyond 2027 or construction does not start as planned	NRC accepted permit (Aug 2026) vs 2H27 target NRC accepted reactor permit in Q3 2026; licensing path confirmed at TD Roundtable. Context reviewed through Oct 23, 2026Last status assessment Oct 25, 2026Compare required operating outcomes Compare scope, accounting basis and period before treating this evidence as progress against an annual requirement.
Increase revenue from current flat $21,000 per quarter	It plans to finish NRC review in 2027 and start construction.	Broken	Revenue remains flat or declines beyond FY27	Revenue: $214,042 FY2026-Q3; GAAP. Published target: Revenue grows above flat levels, aiming for meaningful increase by FY28. Target period is not explicitly aligned with this observation. Source published Aug 12, 2026214,042 USD · source valueSource reportLast status assessment Oct 25, 2026 Measurement source consolidated · GAAP FY2026-Q3 · Period ending Jun 30, 2026 Source: company_financial_results. Reference: f6d6c05f-69b9-4a6d-b615-f212da141feb. Source status: eligible. Compare required operating outcomes Compare scope, accounting basis and period before treating this evidence as progress against an annual requirement.
Control operating cash flow and reduce net losses	Management aims to control losses and improve cash flow.	Broken	Operating cash flow remains negative or net losses worsen through FY27	Cash from operations: $-9.41M FY2026-Q3; GAAP. Published target: Operating cash flow improves toward break-even or better by FY27. Target period is not explicitly aligned with this observation. Source published Aug 12, 2026-9,410,283 USD · source valueSource reportLast status assessment Oct 25, 2026 Measurement source consolidated · GAAP FY2026-Q3 · Period ending Jun 30, 2026 Source: stock_quarterly_financials_fmp. Reference: 2026-Q3. Source status: unverified. Compare required operating outcomes Compare scope, accounting basis and period before treating this evidence as progress against an annual requirement.
Integrate $13M STS acquisition to support growth	A supporting condition in NANO Nuclear Energy, Inc.'s published investment case. The stated target is STS acquisition fully integrated and contributing to growth by FY27.	Intact	STS acquisition fails to integrate or deliver growth benefits by FY27	Qualitative condition This condition has no defined numerical measure. Context reviewed through Oct 23, 2026Last status assessment Oct 25, 2026Compare required operating outcomes Compare scope, accounting basis and period before treating this evidence as progress against an annual requirement.

Stored thesis · Jul 8, 2026. Latest Evidence uses source-matched measurements where available, alongside the last thesis-monitor assessment. Source periods and assessment dates are shown separately. A new measurement does not automatically change the published status or verify an older target.

Incoming Evidence

Compare these dated observations with the operating requirements above

Expectations trend

Same fiscal period

FY2028 · fiscal year ending 2028-09-30 · fmp

FY2028 EPS: comparable history unavailable.

FY2028 revenue: comparable history unavailable.

Exact estimates & source dates

One fiscal period and provider throughout. At least five contributors are required for each plotted metric; missing coverage stays a gap. Axes show the observed range. Counts measure coverage, not revisions.

FY2028 estimate observations · fmp
Snapshot	EPS	Revenue	EPS / revenue analysts
2026-10-01	Unavailable	Unavailable	3 / 3
2026-10-02	Unavailable	Unavailable	3 / 3
2026-10-03	Unavailable	Unavailable	3 / 3
2026-10-04	Unavailable	Unavailable	3 / 3
2026-10-05	Unavailable	Unavailable	3 / 3
2026-10-06	Unavailable	Unavailable	3 / 3
2026-10-07	Unavailable	Unavailable	3 / 3
2026-10-08	Unavailable	Unavailable	3 / 3
2026-10-09	Unavailable	Unavailable	3 / 3
2026-10-10	Unavailable	Unavailable	3 / 3
2026-10-11	Unavailable	Unavailable	3 / 3
2026-10-12	Unavailable	Unavailable	3 / 3
2026-10-13	Unavailable	Unavailable	3 / 3
2026-10-14	Unavailable	Unavailable	3 / 3
2026-10-15	Unavailable	Unavailable	3 / 3
2026-10-16	Unavailable	Unavailable	3 / 3
2026-10-17	Unavailable	Unavailable	3 / 3
2026-10-18	Unavailable	Unavailable	3 / 3
2026-10-19	Unavailable	Unavailable	3 / 3
2026-10-20	Unavailable	Unavailable	3 / 3
2026-10-21	Unavailable	Unavailable	3 / 3
2026-10-22	Unavailable	Unavailable	3 / 3
2026-10-23	Unavailable	Unavailable	3 / 3
2026-10-24	Unavailable	Unavailable	3 / 3
2026-10-25	Unavailable	Unavailable	3 / 3

Revenue and EPS estimates track expectations. They are not delivered results or like-for-like proof of a required annual path.

Compare required revenue and earnings

Analyst view

Monthly observations

Buy / Strong BuyHoldSell / Strong Sell

Exact monthly counts

Monthly rating snapshots · fmp. Missing snapshots are not zero.
Date	Buy*	Hold
2026-05-01	3	1
2026-06-01	4	1
2026-07-01	5	2
2026-08-01	5	2
2026-09-01	6	2
2026-10-01	6	2

*Buy includes Strong Buy; Sell includes Strong Sell. Monthly counts describe the analyst mix, not the firms behind each recent action.

Latest: 6 Buy / Strong Buy · 2 Hold · 0 Sell / Strong Sell

0 upgrades0 downgrades1 maintains

Recent actions · Sep 26–Oct 25 · 1 recorded

Price-target changes

30 days

○ Previous · ● Latest · common dollar scale

Truist FinancialOct 22 · prior Jul 13

$22.00 → $19.00-13.6%

SusquehannaOct 1

$39.00New observation · no comparable prior

$0$21.45$42.90

0 raises · 1 cuts · 0 unchanged · 1 without a comparable prior

How this is measured

Sep 26, 2026–Oct 25, 2026. Each firm's latest positive target is paired only with its immediately prior positive target from the same provider, at most 180 days earlier. Unmatched observations have one dot; conflicting observations are not compared.

Outlook in Brief

The evidence, the remaining questions, and what comes next

What's improving

No recovery evidence is reported in the available driver assessments.

Still unresolved / key risks

Increase revenue from current flat $21,000 per quarterPublished status: Broken
Control operating cash flow and reduce net lossesPublished status: Broken
Integrate $13M STS acquisition to support growthQualitative condition

Next proof point

Dec 17, 2026

Look for updated results and guidance against the published targets, plus direct evidence for unresolved drivers.

Review earnings

Bottom line

3 of 4 published conditions remain under pressure or need verification. The next results need to address those conditions.

The dated weekly assessment and its assumptions are available in Read detailed Outlook.

Historical risk context

Observed price history; separate from operating scenarios

Price sensitivity

3.5%Typical daily move · historical

Downside history

-74.6%Maximum drawdown · trailing year

Read detailed Outlook Company context, assumptions & risks

NANO Nuclear Energy, Inc. outlook in detail

The weekly editorial context below is a separate assessment from the dated monitor evidence above. Recovery observations do not automatically change the published thesis. Unverified outside influences are hypotheses, not measured driver evidence.

Updated Oct 24, 2026

What kind of bet this is

This is a speculative growth investment with a focus on long-term potential. The current thesis state indicates uncertainty due to recent volatility in earnings and management execution.

What's priced into NANO Nuclear Energy, Inc.

The market appears to be pricing in a low level of fragility, suggesting that recent performance has not triggered significant negative sentiment. However, the company's loss-making status and high-risk profile indicate that investors are cautious about future earnings.

What the fundamentals likely do

Management is making progress on key initiatives, such as advancing the KRONOS MMR system and integrating the acquisition of Secured Transportation Services. However, the company remains loss-making, and recent changes show a significant drop in momentum, which could impact future performance.

What NANO Nuclear Energy, Inc. hinges on

The long-term thesis hinges on the ability of NNE to execute on its management priorities and the performance of sector bellwethers. If these companies continue to perform well, it could provide a favorable backdrop for NNE, while any negative guidance from them could pose risks.

Bottom line

In the next 1 to 3 years, NNE's performance will depend on management execution and sector dynamics. Not investment advice.

Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.